Issued 2026-09-16 at $86.49 · now $86.49 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, GPN has typically landed between $73.26 and $99.39 — a range of −15.3% to +14.9% from the issuance price $86.49.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($86.49) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where GPN has typically landed a month from the 2026-09-16 close of $86.49 — the range is history, not a prediction.
- now $86.49 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $85.5 (-1.1%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $79.61–$91.38
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $73.26–$99.39
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-21 | −43.1% | −43.1% | +0.0% |
| 2020-02-20 | −42.9% | −42.9% | +0.0% |
| 2020-02-19 | −36.9% | −36.9% | +0.7% |
| 3 best | |||
| 2020-04-03 | +32.2% | +0.0% | +34.5% |
| 2016-03-18 | +29.1% | +0.0% | +29.6% |
| 2016-03-15 | +28.8% | +0.0% | +29.4% |
4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$156.31
- Analyst target · range $76.00–$111.00$82.00
- Current price · last close 2026-09-16$86.49
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-20 | JOHNSON JOIA M | director | Purchase | 1,213 @ $81.90 | $99K | +38.2% of holding | −8.9% | +2.5% | 4,386 | Form 4 · filed 3 days after the trade |
| 2025-12-11 | BALDWIN ROBERT H B JR | director | Purchase | 10,392 @ $81.42 | $846K | +21.2% of holding | −6.1% | −26.9% | 59,303 | Form 4 · filed 1 day after the trade |
| 2025-12-11 | SHEFFIELD DAVID M | officer | Sale | 2,016 @ $81.41 | $164K | −12.3% of holding | −6.1% | −26.9% | 14,438 | Form 4 · filed 1 day after the trade |
| 2025-12-10 | BALDWIN ROBERT H B JR | director | Purchase | 3,000 @ $80.25 | $241K | +6.5% of holding | −1.9% | −23.4% | 48,911 | Form 4 · filed 2 days after the trade |
| 2025-12-03 | Green David Lawrence | officer | Sale | 11,600 @ $79.99 | $928K | −14.6% of holding | −4.2% | −25.0% | 68,096 | Form 4 · filed 2 days after the trade |
| 2025-11-12 | MCDANIEL CONNIE D | director | Sale | 4,464 @ $77.81 | $347K | −12.9% of holding | +6.6% | −20.9% | 30,014 | Form 4 · filed 2 days after the trade |
| 2025-11-07 | Watson Patricia A | director | Purchase | 1,331 @ $75.06 | $100K | +100.8% of holding | +0.1% | −19.8% | 2,651 | Form 4 · filed 3 days after the trade |
| 2025-08-21 | Cortopassi Robert M | officer | Sale | 4,000 @ $85.52 | $342K | −7.5% of holding | −3.5% | −14.7% | 49,121 | Form 4 · filed 1 day after the trade |
| 2025-08-12 | SHEFFIELD DAVID M | officer | Sale | 2,500 @ $83.03 | $208K | −13.2% of holding | +2.9% | −20.1% | 16,454 | Form 4 · filed 2 days after the trade |
| 2025-08-07 | Steele-Belkin Dara L. | officer | Sale | 2,000 @ $86.00 | $172K | −6.1% of holding | +4.0% | −20.5% | 30,713 | Form 4 · filed 4 days after the trade |
| 2025-05-08 | SHEFFIELD DAVID M | officer | Sale | 2,500 @ $80.79 | $202K | −11.0% of holding | −6.9% | −22.7% | 20,150 | Form 4 · filed 4 days after the trade |
| 2024-12-13 | BALDWIN ROBERT H B JR | director | Purchase | 5,800 @ $116.00 | $673K | +15.7% of holding | −2.7% | −32.4% | 42,738 | Form 4 · filed 3 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
122 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-08 | Cortopassi Robert M | officer | Withheld for tax | 825 | 87,026 | Form 4 |
| 2026-08-04 | Cortopassi Robert M | officer | Withheld for tax | 2,955 | 87,851 | Form 4 |
| 2026-07-29 | Bready Cameron M | director | Withheld for tax | 8,871 | 432,790 | Form 4 |
| 2026-07-29 | Bready Cameron M | director | Option exercise | 9,703 | 441,661 | Form 4 |
| 2026-07-29 | Bready Cameron M | director | Option exercise | 9,703 | 0 | Form 4 |
| 2026-06-01 | Bready Cameron M | director | Withheld for tax | 2,297 | 431,958 | Form 4 |
| 2026-06-01 | Steele-Belkin Dara L. | officer | Withheld for tax | 2,254 | 46,527 | Form 4 |
| 2026-05-01 | Kliphouse Kirsten Marie | director | Award / grant | 3,179 | 9,076 | Form 4 |
| 2026-05-01 | Sankaran Vivek | director | Award / grant | 3,179 | 3,418 | Form 4 |
| 2026-05-01 | Arroyo F. Thaddeus | director | Award / grant | 3,179 | 16,272 | Form 4 |
| 2026-05-01 | Deskus Archana | director | Award / grant | 3,179 | 4,499 | Form 4 |
| 2026-05-01 | BRUNO JOHN G | director | Award / grant | 3,179 | 21,849 | Form 4 |
| 2026-05-01 | JOHNSON JOIA M | director | Award / grant | 3,179 | 6,352 | Form 4 |
| 2026-05-01 | MCDANIEL CONNIE D | director | Award / grant | 3,179 | 33,193 | Form 4 |
| 2026-05-01 | WOODS M TROY | director | Award / grant | 3,939 | 85,795 | Form 4 |
| 2026-05-01 | Watson Patricia A | director | Award / grant | 3,179 | 5,830 | Form 4 |
| 2026-05-01 | PLUMMER WILLIAM B | director | Award / grant | 3,179 | 18,685 | Form 4 |
| 2026-05-01 | Osnoss Joseph | director | Award / grant | 3,179 | 10,902 | Form 4 |
| 2026-03-15 | Whyte Jennifer Bozeman | officer | Withheld for tax | 42 | 8,873 | Form 4 |
| 2026-03-01 | Bready Cameron M | director | Withheld for tax | 3,924 | 434,255 | Form 4 |
| 2026-03-01 | Whipple Joshua J | officer | Withheld for tax | 1,313 | 107,262 | Form 4 |
| 2026-03-01 | Cortopassi Robert M | officer | Withheld for tax | 745 | 90,475 | Form 4 |
| 2026-03-01 | Steele-Belkin Dara L. | officer | Withheld for tax | 204 | 48,781 | Form 4 |
| 2026-03-01 | Whyte Jennifer Bozeman | officer | Withheld for tax | 133 | 8,915 | Form 4 |
| 2026-02-28 | Bready Cameron M | director | Withheld for tax | 9,750 | 438,179 | Form 4 |
| 2026-02-28 | Whipple Joshua J | officer | Withheld for tax | 3,706 | 108,575 | Form 4 |
| 2026-02-28 | Cortopassi Robert M | officer | Withheld for tax | 3,645 | 91,220 | Form 4 |
| 2026-02-28 | Steele-Belkin Dara L. | officer | Withheld for tax | 2,093 | 48,985 | Form 4 |
| 2026-02-28 | SHEFFIELD DAVID M | officer | Award / grant | 1,188 | 16,415 | Form 4 |
| 2026-02-28 | SHEFFIELD DAVID M | officer | Withheld for tax | 755 | 15,660 | Form 4 |
| 2026-02-27 | Bready Cameron M | director | Award / grant | 119,017 | 444,131 | Form 4 |
| 2026-02-27 | Cortopassi Robert M | officer | Award / grant | 40,218 | 93,113 | Form 4 |
| 2026-02-27 | Whipple Joshua J | officer | Award / grant | 37,929 | 110,653 | Form 4 |
| 2026-02-27 | Steele-Belkin Dara L. | officer | Award / grant | 19,619 | 50,015 | Form 4 |
| 2026-02-27 | Viviani Stella Nichole | officer | Award / grant | 19,619 | 19,619 | Form 4 |
| 2026-02-27 | Bready Cameron M | director | Award / grant | 3,798 | 447,929 | Form 4 |
| 2026-02-27 | Cortopassi Robert M | officer | Award / grant | 1,752 | 94,865 | Form 4 |
| 2026-02-27 | Whipple Joshua J | officer | Award / grant | 1,628 | 112,281 | Form 4 |
| 2026-02-27 | Steele-Belkin Dara L. | officer | Award / grant | 1,063 | 51,078 | Form 4 |
| 2026-02-21 | Bready Cameron M | director | Award / grant | 36,534 | 359,663 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-16 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Alan Armstrong | Senate | purchase | 2026-07-21 | 2026-03-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-15 | $1–15K |
| Ro Khanna | House | sale | 2026-05-11 | 2026-04-24 | $1–15K |
| Ro Khanna | House | sale | 2026-05-11 | 2026-04-13 | $1–15K |
| Gilbert Cisneros | House | purchase | 2026-05-08 | 2026-04-14 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-04-07 | 2026-03-10 | $1–15K |
| Ro Khanna | House | sale | 2026-03-09 | 2026-02-17 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-29 | $1–15K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-23 | $1–15K |
| Gilbert Cisneros | House | sale | 2026-01-12 | 2025-12-10 | $15–50K |
| Gilbert Cisneros | House | sale | 2026-01-12 | 2025-12-19 | $1–15K |
| Gilbert Cisneros | House | purchase | 2025-12-15 | 2025-11-18 | $1–15K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.